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four randomly selected regions of a country or state. A core list
of medicines is surveyed, plus a supplementary list of locally
important medicines. For each medicine, prices are sought for
the innovator brand, and the lowest priced generic equivalent at
the facility surveyed. Government procurement prices are also
collected. Prices are compared to an international reference price.
RESULTS: The affordability of a selection of standard treatment
regimens is assessed based on the number of days the lowest paid
unskilled government worker needs to work to purchase the
treatment. Guidance is also given as to how to analyze price com-
ponents (taxes, mark-ups etc.) applied in the distribution chain
from the manufacturer to the patient. CONCLUSIONS: An
Excel workbook, which accompanies the manual, is used to
double enter, error check and analyze the data. The manual also
includes a chapter which outlines a range of policy option to
lower medicine prices based on the evidence gathered. Currently
over 40 national or state surveys are underway or completed (in
addition to 9 pilot surveys). To aid price transparency, survey
data, reports and other information is freely available on HAI’s
website (www.haiweb.org/medicineprices).
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OBJECTIVES: To aid in the understanding of cost effective
wound healing technology advances, KCI, Inc. collaborated with
Milliman to produce a cost model vacuum assisted closure
therapy (V.A.C. Therapy) for four wound types. METHODS:
Hospital costs associated with speciﬁc wound types (Diabetic
Ulcers, Diabetic Amputations, Orthopedic Trauma and Compli-
cated Sternotomies were obtained from medical administrative
claims databases. These ﬁgures were used as the basis for costs
attributed to patients requiring wound care treatment. The inter-
active model allows selection of a given hospital, their contracted
price of V.A.C. Therapy, and their expected number of wounds
treated during a year period. Potential cost savings scenarios
were obtained by modeling the clinical paths of treatment for
these four wound types and associating the expected costs for
alternative treatments. Potential cost savings calculations were
produced for each of the four wound types. RESULTS: V.A.C.
Therapy results in lower cost to the hospital compared to stan-
dard wound treatment. The differences range from 9% for Dia-
betic Ulcers to 23% for Complicated Sternotomies, including the
cost of the V.A.C. Therapy. Potential savings are obtained pri-
marily from shorter hospital stays due to increased efﬁciency in
meeting discharge criteria. Other sources of potential savings
based on this hospital model include fewer complications and
greater wound healing success, resulting in fewer repeat treat-
ments. CONCLUSIONS: This interactive model is a useful tool
for exploring the potential value of advancing wound care treat-
ment options and provides information on the expected costs of
treating patients with four speciﬁc wound types.
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OBJECTIVES: Analysis of administrative claims data are often
criticized for lacking adjustments for severity. We explored if
disease-speciﬁc cost (DSC) quintiles may be indicative of disease
severity in an examination of several diseases. METHODS: The
Human Capital Management Services Reference Research Data-
base of over 300,000 employees was used to examine the annual
DSC of several diseases from 2001–2004. DSCs were calculated
as the sum of the disease-speciﬁc medical costs (DSMC) for ser-
vices tied to disease related ICD-9-CM codes and the disease-
speciﬁc prescription cost (DSRxC) for outpatient medicines.
Diseases included Back Disorders, Bipolar Disorder, Cancer,
Functional Dyspepsia, Gastroesophageal Reﬂux Disease
(GERD), Headaches, Neuropathic Disorders, and Osteoarthritis.
Based on DSC, subjects in each disease state were rank ordered
into 5 cost quintiles (20% each) ranging from lowest-highest cost
quintile. Within and across diseases pairwise differences in the
quintile distributions were assessed using Chi-squared tests.
RESULTS: The range of the sum of costs related to each speciﬁc
disease state found in the highest cost quintile (from lowest to
highest) were the following (including percentage of subjects in
the highest quintile): 1) Functional Dyspepsia (3.54%, DSMC
$1,171, DSRxC $1,278); 2) GERD (2.57%, DSMC $4,886
DSRxC $1,108); 3) Bipolar Disorder (2.37%, DSMC $21,427,
DSRxC $2,354) 4) Headaches (1.14%, DSMC $6,846, DSRxC
$1,134); 5) Back Disorders (0.53%, DSMC $39,807, DSRxC
$570; 6) Osteoarthritis (0.51%, DSMC $44,677, DSRxC $59);
7) Neuropathic Disorders (0.20%, DSMC $80,463, DSRxC
$741); and 8) Cancer (0.38%, DSMC $108,678; DSRxC $167).
All pairwise comparisons were signiﬁcant (FD and GERD, P =
0.0468) and the remaining comparisons (P ≤ 0.001). CON-
CLUSIONS: In all diseases explored, 3.5% of subjects or less
consume the highest 20% of costs. These cost-comparison results
may suggest that cost quintiles are indicative of severity in all
disease states. Further investigation is warranted to conﬁrm this
relationship.
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OBJECTIVE: The National Violent Death Reporting System
(NVDRS) is a registry of violent deaths in the United States. The
NVDRS aggregates data from multiple sources, including death
certiﬁcates, medical examiner and coroner reports, and crime lab-
oratories. The NVDRS currently obtains data from 17 states, but
is designed to eventually be a national registry. This study evalu-
ates how NVDRS can serve as a model for other developing
national public health (PH) registries. METHODS: A team of PH
professionals compared the NVDRS to other national 
registries (immunization registry, cancer registries, National
